Try our Advanced Search for more refined results

December 12, 2011

Securities and Exchange Commission v. Stiefel Laboratories Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 23, 2020

    Fla. Lab, Ex-CEO Agree To Pay $37M To End SEC Fraud Suit

    Stiefel Laboratories Inc. and its former chief executive have agreed to pay the U.S. Securities and Exchange Commission $37 million to end claims they defrauded investors and employees by rebuying undervalued stock before a $2.9 billion sale to GlaxoSmithKline PLC, according to documents filed Thursday in a Florida federal court.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!